Pharma does this all the time. What’s even worse is they will buy the nda/patent and trial it for a completely different application, refile and get a year of exclusivity as the first generic on the market. And the price will skyrocket.
I spent almost two decades working for Tycho, Covidien, Mallinckrodt, GSK/Haleon and several more. The only thing redeeming was the people at the bottom. The rest is just shit all the way up.
Pharma does this all the time. What’s even worse is they will buy the nda/patent and trial it for a completely different application, refile and get a year of exclusivity as the first generic on the market. And the price will skyrocket.
I spent almost two decades working for Tycho, Covidien, Mallinckrodt, GSK/Haleon and several more. The only thing redeeming was the people at the bottom. The rest is just shit all the way up.